BSX Q1 2022 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$105B

Q1 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$3.0B+10.0% YoY

Gross Profit

$1.8B60.9% margin

Operating Income

$457M15.1% margin

Net Income

$111M3.7% margin

EPS (Diluted)

$0.07

QoQ Revenue Growth

-3.2%

Cash Flow

Operating Cash Flow

-$58M

Free Cash Flow

-$189M

Stock-Based Comp.

$52M

Balance Sheet

Total Assets

$32.3B

Total Liabilities

$15.6B

Stockholders' Equity

$16.7B

Cash & Equivalents

$325M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.0B	$2.8B	+10.0%
Gross Profit	$1.8B	$1.7B	+10.6%
Operating Income	$457M	$360M	+26.9%
Net Income	$111M	$341M	-67.4%

Revenue Segments

Cardiovascular

$1.9B62%

MedSurg

$1.2B38%

Geographic Segments

UNITED STATES

$1.8B59%

Non-US

$1.2B41%